Pharmacogenomics
Journal Title
- Pharmacogenomics
ISSN
- E 1744-8042 | P 1462-2416 | 1462-2416 | 1744-8042
Publisher
- Ashley Publications Ltd.
Listed on(Coverage)
| JCR | 2003-2019 |
|---|---|
| SJR | 2001-2019 |
| CiteScore | 2011-2019 |
| SCI | 2010-2019 |
| SCIE | 2010-2021 |
| CC | 2016-2021 |
| SCOPUS | 2017-2020 |
| MEDLINE | 2016-2021 |
| EMBASE | 2016-2020 |
Active
- Active
based on the information
- SCOPUS:2020-10
Country
- ENGLAND
Aime & Scopes
- Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community, including: /// The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies /// Emerging technologies for accessing and exploiting genomic information /// Reviews of genotyping and clinical data in particular therapeutic areas /// Development of novel diagnostic products and strategies Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field. The journal welcomes unsolicited article proposals.
Article List
1 - 0 out of 0 results.
1